VitaNova Life Sciences (VNOV) Shares Outstanding (2018 - 2026)

VitaNova Life Sciences (VNOV) has 10 years of Shares Outstanding (Entity) data on file, last reported at $8.3 million in Q2 2026.

• Quarterly Shares Outstanding (Entity) fell 66.67% year-over-year to $8.3 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $8.3 million (down 66.67% YoY) and the FY2026 annual result came in at $8.3 million, down 66.67% from the prior year.
• Shares Outstanding (Entity) held at $8.3 million in Q2 2026, from $8.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $25.0 million in Q3 2024 to a low of $5.9 million in Q1 2022.
• A 5-year average of $12.8 million and a median of $7.2 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) surged 326.01% — and 2026, when it tumbled 66.67%.
• Tracing VNOV's Shares Outstanding (Entity) over 5 years: stood at $5.9 million in 2022, then changed by 0.0% to $5.9 million in 2023, then surged by 326.01% to $25.0 million in 2024, then changed by 0.0% to $25.0 million in 2025, then plunged by 66.67% to $8.3 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $8.3 million (Q2 2026), $8.3 million (Q1 2026), and $25.0 million (Q4 2025), per Business Quant data.